Tomoko Kumagai, Farooq Rahman and Andrew M. Smith
Nutrients
One in three people will develop cancer at some point in their lives. Radiotherapy is used to treat approximately 50% of cancer patients. However, its toxic effect to the surrounding normal healthy tissue remains a major drawback.
Radiation-induced bowel injury is an undesirable and often debilitating consequence of radiation therapy for cancer, and most commonly occurs with radiotherapy to the abdomen and pelvic region. Between 60 and 80% of patients develop early intestinal inflammation which recedes within a few months; however, a significant number develop ‘delayed’ bowel toxicity, characterised by chronic inflammation and ischaemia resulting in irreversible mucosal atrophy, intestinal fibrosis and microvascular sclerosis. Once established, this is a chronic progressive irreversible condition.
The pathophysiology of radiation-induced bowel injury is poorly understood, although we now know that it derives from a complex interplay of epithelial injury and alterations in the enteric immune, nervous, and vascular systems in genetically predisposed individuals. Furthermore, evidence supporting a pivotal role for the gut microbiota in the development of radiation-induced bowel injury has been growing.
In this review, we aim to appraise our current understanding of radiation-induced bowel injury and the role of the microbiome in its pathogenesis as well as prevention and treatment. Greater understanding of the relationship between the disease mechanism of radiation-induced bowel injury and gut microbiome might shed light on potential future prevention and treatment strategies through the modification of a patient’s gut microbiome.
Links
Student story
Tomoko Kumagai, from Japan, joins us after receiving a prestigious MRC Clinical Research Training Fellowship:
| Link | Link | Link | Link | Link |
Link
From movement to cognitive maps: AI models show how learning to move shapes the brain's maps.
A new study reveals that how young animals learn to move may shape how their brains build navigation maps, offering key insights into how early experiences wire the developing brain.
04 Mar 2026
Nasser Fares Massoud appointed Chair of the MBA & EMBA External Advisory Board at UCL GBSH
Nasser Fares Massoud brings extensive global expertise and strategic sector leadership as the new Chair of UCL Global Business School for Health's MBA & EMBA External Advisory Board
02 Mar 2026
